Caricamento...
NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma
Glioblastoma (GBM) is the most common primary intracranial malignancy. GBM still exhibits high recurrence and mortality rates even following combined treatment with surgery, radiotherapy and chemotherapy, Therefore, the identification of novel therapeutic targets is urgent. Previous research has sho...
Salvato in:
| Pubblicato in: | Oncol Rep |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
D.A. Spandidos
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6667917/ https://ncbi.nlm.nih.gov/pubmed/31322259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.7227 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|